Evidence map›Paper›PMID 42183918›Full record

ReviewClinical rheumatology2026

Fibromyalgia in men: beyond invisibility-a biopsychosocial and clinical perspective in rheumatology.

André Pontes-Silva

Abstract readReview
In one paragraph

Review in Clinical rheumatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

André Pontes-SilvaPostgraduate Program in Physical Education, Federal University of Maranhão, São Luís, MA, Brazil. andre.pontes@ufma.br.ORCID http://orcid.org/0000-0002-3983-5342

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fibromyalgia is a chronic pain syndrome traditionally perceived as a predominantly female condition, although growing evidence suggests that this view may partly reflect diagnostic and sociocultural biases rather than true epidemiological differences. This perspective critically examines fibromyalgia in men as an underrecognized and understudied clinical entity. The authors propose an integrative conceptual framework in which the invisibility of men with fibromyalgia emerges from the interaction between sociocultural barriers to healthcare-seeking, clinician-related diagnostic bias, and heterogeneous symptom expression influenced by biological and psychosocial factors. Men may delay seeking medical care due to cultural expectations of masculinity and frequently encounter skepticism regarding symptoms such as diffuse pain, fatigue, and psychological distress. Although core symptoms are shared across sexes, men may differ in coping strategies, illness perception, and healthcare interaction. Emerging evidence also suggests possible neurophysiological and functional alterations, including small fiber pathology, reduced muscular strength, gait impairments, and psychological comorbidities. However, current evidence remains limited by small samples and methodological heterogeneity. The article argues that understanding fibromyalgia in men is essential not to establish rigid sex-specific phenotypes, but to improve diagnostic sensitivity, promote biopsychosocial and gender-sensitive care, and expand the understanding of heterogeneity within chronic pain disorders.

Indexed as

FibromyalgiaRheumatologyChronic PainHumansMaleSex FactorsBiological differencesFemale diseaseFibromyalgia

Identifiers

PMID42183918
PMCPMC13341908

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.